Loading…
Enveric Biosciences, Inc. is projected to decline to $1.97 by 2027, a -8% move from its current price of $2.14. ENVB is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $1.98 | $2.14 | $2.30 | -0.10% |
| May 30 | $1.92 | $2.14 | $2.37 | -0.19% |
| May 31 | $1.88 | $2.13 | $2.43 | -0.29% |
| Jun 1 | $1.84 | $2.13 | $2.47 | -0.39% |
| Jun 2 | $1.80 | $2.13 | $2.51 | -0.48% |
| Jun 3 | $1.77 | $2.13 | $2.55 | -0.58% |
| Jun 4 | $1.75 | $2.13 | $2.59 | -0.67% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.75 | $2.13 | $2.59 | -0.67% |
| Week 2 | $1.60 | $2.11 | $2.79 | -1.34% |
| Week 3 | $1.49 | $2.10 | $2.95 | -2.01% |
| Week 4 | $1.41 | $2.08 | $3.08 | -2.67% |
| Week 5 | $1.33 | $2.07 | $3.21 | -3.32% |
| Week 6 | $1.27 | $2.05 | $3.32 | -3.97% |
| Week 7 | $1.21 | $2.04 | $3.43 | -4.62% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Enveric Biosciences, Inc. is a biotechnology company focused on the development of small molecule neuroplastogenic therapeutics that address unmet needs in psychiatric and neurological disorders in the United States.
Its lead drug candidate is EB-003, a novel derivative of DMT in preclinical development for mental health indications.
The company also develops EVM401 series comprising novel phenylalkylamines and indolethylamines, as well as mescaline-derived compounds to target addiction and neuropsychiatric disorders; and Psybrary, a proprietary library. Enveric Biosciences, Inc. is headquartered in Cambridge, Massachusetts.
Enveric Biosciences, Inc. (ENVB) trades at $2.21 per share with a market capitalization of $8.14M and is ranked 5213.
The current price outlook, based on the published year-by-year forecast, shows a path that begins near the present level and features fluctuating averages over the next several years.
Longer term, the forecast envisions higher averages by 2050, with the 2050 average price at $5.76 and a maximum implied price of $13.26.
A major floor 16.4% below — a decisive break under it would weaken the trend.
The nearest floor, 15.0% below — buyers have tended to step in here.
The nearest ceiling, 148.6% above — a clean break opens room to run.
A major ceiling 208.1% above — clearing it would confirm fresh momentum.
Key ENVB support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ENVB market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.20 | Sell | $2.20 | Sell |
| MA 10 | $2.22 | Sell | $2.34 | Sell |
| MA 20 | $2.84 | Sell | $2.60 | Sell |
| MA 50 | $2.65 | Sell | $2.77 | Sell |
| MA 100 | $2.77 | Sell | $4.85 | Sell |
| MA 200 | $5.54 | Sell | $70.32 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 37.75 | Neutral |
| Stoch RSI (14) | 10.14 | Buy |
| CCI (20) | -71.74 | Neutral |
| Williams %R (14) | -97.17 | Info |
| MACD (12,26,9) | -0.10 | Sell |
| ROC (12) | -24.91 | Sell |
| Bollinger %B (20,2) | 0.28 | Neutral |
| Stochastic %K (14) | 2.83 | Buy |
| TRIX (15) | -0.67 | Sell |
| Awesome (5,34) | -0.77 | Sell |
| Ultimate (7,14,28) | 29.90 | Buy |
| Momentum (10) | -0.38 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 2.20 | Sell |
| ADX (14) | 22.40 | Sell |
| ATR (14) | 0.17 | Info |
The 30-day technical picture is Bearish, reflecting near-term downside pressure.
RSI14 is 40, with a SMA50 of $2.64 and a SMA200 of $5.66. The key support level sits at $1.82 and the resistance at $5.32. The thirty-day price range spans from $1.32 to $3.71, indicating limited upside momentum in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.79 | $2.14 | $2.53 | 0% | Neutral | |
| $1.42 | $1.97 | $2.97 | -8% | Neutral | |
| $1.62 | $2.39 | $3.81 | +12% | Neutral | |
| $1.90 | $2.95 | $4.95 | +38% | Bullish | |
| $1.79 | $2.92 | $5.08 | +36% | Bullish | |
| $1.31 | $2.23 | $4.02 | +4% | Neutral | |
| $1.38 | $2.44 | $4.53 | +14% | Neutral | |
| $1.36 | $2.52 | $4.81 | +18% | Neutral | |
| $1.40 | $2.70 | $5.28 | +26% | Bullish | |
| $1.86 | $3.71 | $7.43 | +73% | Bullish | |
| $1.71 | $3.79 | $8.34 | +77% | Bullish | |
| $2.51 | $5.59 | $12.85 | +161% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $1.79 | $2.14 | $2.55 | +0.00% |
| June 2026 | $1.74 | $2.09 | $2.60 | -2.36% |
| July 2026 | $1.61 | $1.96 | $2.50 | -6.21% |
| August 2026 | $1.65 | $2.04 | $2.65 | +4.05% |
| September 2026 | $1.68 | $2.10 | $2.77 | +2.84% |
| October 2026 | $1.52 | $1.91 | $2.56 | -8.69% |
| November 2026 | $1.40 | $1.79 | $2.42 | -6.53% |
| December 2026 | $1.44 | $1.85 | $2.53 | +3.10% |
Click any year to see its month-by-month ENVB forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect ENVB to range from $1.79 to $2.53 through 2026. The $2.14 average target implies a 0% move from current prices. Price action looks broadly range-bound.
The ENVB price prediction for 2027 points to an average of $1.97 (low $1.42, high $2.97) — a potential decline of -8% on today's $2.14. A consolidation phase looks the most probable path here.
In 2028, ENVB is projected to trade between $1.62 and $3.81, averaging $2.39 — a potential gain of +12% from today's $2.14. That is up +21% on the projected 2027 average. Price action looks broadly range-bound.
Enveric Biosciences, Inc.'s 2029 outlook centres on $2.95, within a $1.90 to $4.95 range. That is up +24% on the projected 2028 average. That marks a +38% change versus current levels. Buyers look set to stay in control over this stretch.
By 2030, ENVB could reach as high as $5.08, with a base case around $2.92 and support toward $1.79 — roughly +36% from $2.14. Momentum favours further upside here.
Expect ENVB to range from $1.31 to $4.02 through 2031. The $2.23 average target implies a +4% move from current prices. That is -24% versus the projected 2030 average. A consolidation phase looks the most probable path here.
The ENVB price prediction for 2032 points to an average of $2.44 (low $1.38, high $4.53) — a potential gain of +14% on today's $2.14. Price action looks broadly range-bound.
In 2033, ENVB is projected to trade between $1.36 and $4.81, averaging $2.52 — a potential gain of +18% from today's $2.14. That is up +3% on the projected 2032 average. A consolidation phase looks the most probable path here.
Enveric Biosciences, Inc.'s 2034 outlook centres on $2.70, within a $1.40 to $5.28 range. That is up +7% on the projected 2033 average. That marks a +26% change versus current levels. Momentum favours further upside here.
By 2035, ENVB could reach as high as $7.43, with a base case around $3.71 and support toward $1.86 — roughly +73% from $2.14. Buyers look set to stay in control over this stretch.
Expect ENVB to range from $1.71 to $8.34 through 2040. The $3.79 average target implies a +77% move from current prices. That is up +2% on the projected 2035 average. Momentum favours further upside here.
The ENVB price prediction for 2050 points to an average of $5.59 (low $2.51, high $12.85) — a potential gain of +161% on today's $2.14. Buyers look set to stay in control over this stretch.
Investing $1,000 in ENVB today (≈ 467.28972 ENVB) could be worth
$2,611.32
+$1,611.32 (+161%) by 2050 · US Dollar
Based on the average projected ENVB price of $5.59 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ENVBwould be worth at today's price.
$1,000 invested in ENVB on May 27, 2025 (≈ 65.616799 ENVB) would be worth
$140.42
-$859.58 (-86.0%) today · 0.14× · US Dollar
Based on a ENVB entry price of $15.24 vs. today's $2.14.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.2 | $972.73 | -2.7% |
| 1 month ago | $5.1 | $419.61 | -58.0% |
| 3 months ago | $2.32 | $922.41 | -7.8% |
| 6 months ago | $5.74 | $372.82 | -62.7% |
| 1 year ago | $15.24 | $140.42 | -86.0% |
| All time (5.0y) ago | $321,300 | $0.01 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ENVB forecast.
Our base-case forecast reaches $4.30 around 2050.
Implied market cap at $4.30: $15.83M
The multi-year forecast shows a mix of near-term stability and longer-term upside in the average price. The 2026 average is $2.21, with 2027 at $2.01, 2028 at $2.50, 2029 at $3.06, and 2030 at $2.97, illustrating a choppy path in the early years.
Beyond 2030, the forecast continues with 2031 at $2.32, 2032 at $2.54, 2033 at $2.58, 2034 at $2.80, and 2035 at $3.85, followed by 2040 at $3.96 and 2050 at $5.76. The corresponding ROI percentages are 0% in 2026; -8.9% in 2027; 13.2% in 2028; 38.4% in 2029; 34.4% in 2030; 4.9% in 2031; 14.8% in 2032; 16.5% in 2033; 26.7% in 2034; 74.3% in 2035; 79.3% in 2040; and 160.9% in 2050.
Sentiment shifts from Neutral for 2026–2033 to Bullish for 2034 onward, reflecting a more favorable long‑term outlook despite mid‑term fluctuations. These projections are estimates and not guarantees, and actual results will vary based on a range of factors.
Tap a question to reveal the answer.
The forecast lists an average price of $2.97 with a ROI of 34.4% and sentiment BULLISH for 2030.
Forecasts show Neutral sentiment in 2026 and 2027 with a negative ROI of -8.9% in 2027, followed by positive ROIs of 13.2% in 2028 and 38.4% in 2029. The outlook becomes Bullish in later years (2034 onward) with higher averages (e.g., 2035 average $3.85) and a long‑term ROI of 160.9% by 2050, though outcomes are not guaranteed.
Yes. The forecast for 2035 shows a max of $7.72 with a 74.3% ROI and Bullish sentiment.
Current price is $2.21 and market capitalization is $8.14M.
The 2040 forecast shows an average price of $3.96, a max of $8.72, a min of $1.78, with an ROI of 79.3% and Bullish sentiment.
Enveric Biosciences, Inc. Community Discussion
0Share your Enveric Biosciences, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.